US Patent 9901623 Rapid-acting insulin compositions
Patent 9901623 was granted and assigned to Eli Lilly and Company on February, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 19, 2016
Date of Patent
February 27, 2018
Patent Applicant
Patent Application Number
15241412
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9901623 Rapid-acting insulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
